{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:23:29Z","timestamp":1787509409187,"version":"build-2736575974"},"reference-count":131,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The opioid epidemic has resulted in increased opioid\u2010related critical care admissions, presenting challenges in acute pain management. Limited guidance exists in the management of critically ill patients with opioid use disorder (OUD). This narrative review provides the intensive care unit clinician with guidance and treatment options, including nonopioid analgesia, for patients receiving medications for OUD and for patients actively misusing opioids. Verification and continuation of the patient's outpatient medications for OUD regimen, specifically buprenorphine and methadone formulations; assessment of pain and opioid withdrawal; and treatment of acute pain with nonopioid analgesia, nonpharmacologic strategies, and short\u2010acting opioids as needed, are all essential to adequate management of acute pain in patients with OUD. A multidisciplinary approach to treatment and discharge planning in patients with OUD may be beneficial to engage patients with OUD early in their hospital stay to prevent withdrawal, stabilize their OUD, and reduce the risk of unplanned discharge and other associated morbidity.<\/jats:p>","DOI":"10.1002\/jcph.1999","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T07:48:33Z","timestamp":1636876113000},"page":"449-462","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care"],"prefix":"10.1002","volume":"62","author":[{"given":"Kathryn","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Pharmacy Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Beth Israel Deaconess Medical Center  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Abdukalikov","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McAullife","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Whitesell","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Richard","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sauer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine Maine Medical Center  Portland Maine USA"},{"name":"Spectrum Healthcare Partners  South Portland Maine USA"},{"name":"Department of Critical Care Maine Medical Center  Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Quaye","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine Maine Medical Center  Portland Maine USA"},{"name":"Spectrum Healthcare Partners  South Portland Maine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"e_1_2_10_3_1","unstructured":"AhmadFBRL SuttonP. Provisional drug overdose death counts.https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug\u2010overdose\u2010data.htm. Published2021. Accessed August 18 2021."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.04.022"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201701-022OC"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182783b72"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01759.x"},{"key":"e_1_2_10_8_1","volume-title":"Barriers to Broader Use of Medications to Treat Opioid Use Disorder","author":"National Academies of Sciences E, and Medicine"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3544"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.03.003"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003299"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2019.06.032"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2013"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1604339"},{"key":"e_1_2_10_15_1","volume-title":"Medications for Opioid Use Disorder","author":"SAMHSA","year":"2020"},{"key":"e_1_2_10_16_1","first-page":"1","volume-title":"The CBHSQ Report","author":"Alderks CE","year":"2013"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_2_10_19_1","unstructured":"Lexicomp. Methadone.http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7262?cesid=7bLqf4JMFoH&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dmethadone%26t%3Dname%26va%3Dmethadone. Accessed August 20 2021."},{"key":"e_1_2_10_20_1","unstructured":"Lexicomp. Buprenorphine.http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6483?cesid=3R6y4peJAD5&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dbuprenorphine%26t%3Dname%26va%3Dbuprenorphine. Accessed August 23 2021."},{"key":"e_1_2_10_21_1","unstructured":"Lexicomp. Buprenorphine and naloxone.http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6483?cesid=3R6y4peJAD5&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dbuprenorphine%26t%3Dname%26va%3Dbuprenorphine. Accessed August 20 2021."},{"key":"e_1_2_10_22_1","unstructured":"Lexicomp. Naltrexone.http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7339?cesid=4eFUaS8Y8sU&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dnaltrexone%26t%3Dname%26va%3Dnaltrexone. Accessed August 20 2021."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511841378.026"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz105"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1800222"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(80)90180-5"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.03.023"},{"key":"e_1_2_10_30_1","unstructured":"Confidentiality of substance use disorder patient records.Fed Regist.2020;42986\u201343039. To be codified at 42 CFR \u00a72.https:\/\/www.federalregister.gov\/documents\/2020\/07\/15\/2020\u201014675\/confidentiality\u2010of\u2010substance\u2010use\u2010disorder\u2010patient\u2010records\/. Accessed November 29 2021."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230802245519"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-2-200601170-00010"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab166"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.08.010"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-013-9914-2"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2010.58.4.338"},{"issue":"4","key":"e_1_2_10_37_1","first-page":"229","article-title":"Methadone, QTc prolongation and torsades de pointes: current concepts, management and a hidden twist in the tale?","volume":"4","author":"Mujtaba S","year":"2013","journal-title":"J Cardiovasc Dis Res"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03767.x"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_163_17"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312469982"},{"key":"e_1_2_10_41_1","unstructured":"Suboxone [package insert]. In.Richmond VA:Reckitt Benckiser Pharmacueticals Inc.;2010."},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny217"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.044"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny019"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5475"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02455.x"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.121"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5070-7"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2015.01.036"},{"issue":"2","key":"e_1_2_10_50_1","first-page":"128","article-title":"Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial","volume":"47","author":"Sato H","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202005-554CME"},{"key":"e_1_2_10_52_1","unstructured":"AlkermesI. Pain management: when reversal of vivitrol blockade is required for pain management.https:\/\/www.vivitrol.com\/content\/pdfs\/prescribing\u2010information.pdf. Accessed October 15 2021."},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.02.006"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-01020-4"},{"key":"e_1_2_10_55_1","unstructured":"AlkermesI. Vivitrol (naltrexone for extended\u2010release injectable suspension) [package insert].Waltham MA:Alkermes Inc;2010."},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000611"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0310-5"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596.dsm05"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.1000146"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2002.02047.x"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(80)90455-X"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03016532"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199804000-00015"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2016-134047"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018786832"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12128"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.4097\/kja.d.18.27056"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001226"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.12.1427"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.3.206"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.56"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000002292"},{"key":"e_1_2_10_73_1","unstructured":"National Drug Threat Assessment. DEA\u2010DCT\u2010DIR\u2010032\u201018.https:\/\/www.dea.gov\/sites\/default\/files\/2018-11\/DIR-032-18%202018%20NDTA%20final%20low%20resolution.pdf\/. Published2018. Accessed November 29 2021"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01236-4"},{"key":"e_1_2_10_75_1","unstructured":"National Center for Injury Prevention and Control. Urine drug testing.https:\/\/stacks.cdc.gov\/view\/cdc\/59085\/. Published2018. Accessed November 29 2021."},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.4\/hkleber"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30852-7"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2733"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/ANA.0000000000000020"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1027-0"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1342973"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2017.01.006"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2017"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31817e2fc9"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.05.016"},{"key":"e_1_2_10_87_1","volume-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13th ed","author":"Patel HH","year":"2017"},{"issue":"5","key":"e_1_2_10_88_1","first-page":"456","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Schwenk ES","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.01.020"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.12.012"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066602239122"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181b6a783"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000630"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.00973.x"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9784.114239"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200212000-00046"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000152186.89020.36"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer083"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2018.06.002"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003317"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003428"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2096"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066617706907"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000075837.67275.36"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2042"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018768451"},{"key":"e_1_2_10_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2223"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.19.13447-5"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14579"},{"key":"e_1_2_10_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3182ab1b08"},{"issue":"9","key":"e_1_2_10_111_1","first-page":"1787","article-title":"Improved outcomes associated with the liberal use of thoracic epidural analgesia in patients with rib fractures","volume":"18","author":"Jensen CD","year":"2017","journal-title":"Pain Med"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199905000-00011"},{"key":"e_1_2_10_113_1","article-title":"Epidural analgesia for severe chest trauma: an analysis of current practice on the efficacy and safety","volume":"2019","author":"Peek J","year":"2019","journal-title":"Crit Care Res Pract"},{"key":"e_1_2_10_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14580"},{"issue":"7","key":"e_1_2_10_115_1","article-title":"Epidural local anaesthetics versus opioid\u2010based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery","volume":"7","author":"Guay J","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/560879"},{"key":"e_1_2_10_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200407000-00032"},{"key":"e_1_2_10_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.794"},{"key":"e_1_2_10_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-0770(05)80138-7"},{"key":"e_1_2_10_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.874"},{"key":"e_1_2_10_121_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S75160"},{"key":"e_1_2_10_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03019866"},{"key":"e_1_2_10_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7612-0"},{"key":"e_1_2_10_124_1","doi-asserted-by":"publisher","DOI":"10.4037\/ajcc2004.13.4.292"},{"issue":"23","key":"e_1_2_10_125_1","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons \u2010 United States, 2014","volume":"64","author":"Wheeler E","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_10_126_1","unstructured":"Evzio (naloxone hydrochloride injection solution) [package insert]. Richmond VA: Kaleo Inc.; 2021."},{"key":"e_1_2_10_127_1","unstructured":"Narcan nasal spray [package insert]. Plymouth Meeting PA: Adapt Pharma Inc.; 2020."},{"key":"e_1_2_10_128_1","article-title":"Expanding access to naloxone: a review of distribution strategies","author":"Weiner JMS","journal-title":"Issue Brief"},{"key":"e_1_2_10_129_1","unstructured":"ProjectS. State naloxone access rules and resources.https:\/\/www.safeproject.us\/naloxone\u2010awareness\u2010project\/state\u2010rules\/. Published2019. Accessed October 18 2021."},{"key":"e_1_2_10_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000633"},{"key":"e_1_2_10_131_1","unstructured":"U.S. Department of Health & Human Services. HHS releases new buprenorphine practice guidelines expanding access to treatment for opioid use disorder.https:\/\/www.hhs.gov\/about\/news\/2021\/04\/27\/hhs-releases-new-buprenorphine-practice-guidelines-expanding-access-to-treatment-for-opioid-use-disorder.html\/. Published2021. Accessed December 3 2021."},{"key":"e_1_2_10_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000635"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.1999","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T09:53:51Z","timestamp":1693130031000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1002\/jcph.1999"],"URL":"https:\/\/doi.org\/10.1002\/jcph.1999","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2021-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}